HZHuan Zhao

Huan Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huan Zhao has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Huiqin Guo

    Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    2 shared publications
  • Zhi-Hui Zhang

    Section of Cytopathology, Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

    2 shared publications
  • Changming An

    Department of Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    1 shared publication
  • Chunyan Yang

    Department of Public Health, Liaocheng People′s Hospital, Liaocheng, China

    1 shared publication
  • Cong Wang

    Department of Pathology National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

    1 shared publication
  • Cong Wang

    Cytopathology Section, Department of Pathology, National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences, Peking Union Medical College Beijing China

    1 shared publication

Latest Publications

  • Immunocytochemical detection by a fully automated immunostainer for assisting subclassification of pulmonary tumors on ThinPrep slides in real‐life clinical samples: A single‐institution experience

    by LinLin Zhao, HaiYue Ma, Yue Sun, Cong Wang, XinXiang Chang, HuiQin Guo, Huan Zhao, ZhiHui Zhang

    Introduction: This study aims to investigate the feasibility and reliability of ThinPrep slides in detecting the subclassification of lung cancer and develop a process for immunocytochemistry (ICC) with optimized staining steps of an automated immunostainer.Methods: Cytomorphology and ancillary ICC by automated immunostainer on ThinPrep slides were performed to subclassify 271 cytology cases of pulmonary tumor, which were stained with 2 or more of the following antibodies: p40, p63, thyroid transcription factor‐1 (TTF‐1), Napsin A, synaptophysin (Syn), and CD56.Results: The accuracy of cytological subtyping was improved from 67.2% to 92.7% (p < .0001) after ICC. The accuracy of cytomorphology combined with ICC results for lung squamous‐cell carcinoma (LUSC), lung adenocarcinomas (LUAD), and small cell carcinoma (SCLC) was 89.5% (51 of 57), 97.8% (90 of 92), and 98.8% (85 of 86), respectively. The sensitivity and specificity of 6 antibodies were as follows: p63 (91.2%, 90.4%) and p40 (84.2%, 95.1%) for LUSC, TTF‐1(95.6%, 64.6%) and Napsin A (89.7%, 96.7%) for LUAD and Syn (90.7%, 60.0%) and CD56 (97.7%, 50.0%) for SCLC, respectively. P40 expression on ThinPrep slides had the highest agreement (κ = 0.881) with immunohistochemistry (IHC) results, followed by p63 (κ = 0.873), Napsin A (κ = 0.795), TTF‐1 (κ = 0.713), CD56 (κ = 0.576), and Syn (κ = 0.491).Conclusion: The result of ancillary ICC on ThinPrep slides by fully automated immunostainer was in good agreement with the gold standard in pulmonary tumors subtype and immunoreactivity, objectively achieving accurate subtyping in cytology.


  • Open Access

    Application of the Milan System for Reporting Salivary Gland Cytopathology: A systematic review and meta‐analysis

    by Zhaoyang Wang, Huan Zhao, Huiqin Guo, Changming An

    Background: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) is a standard, evidence‐based classification system for salivary gland fine‐needle aspiration (SG‐FNA). Since it was published in 2018, many researchers across the world have applied this uniform reporting system to their cohorts.Methods: The authors comprehensively reviewed cohort studies conducted since publication of the MSRSGC and performed a meta‐analysis. The risk of neoplasm and the risk of malignancy (ROM) were calculated for each diagnostic category, and their diagnostic efficacy was evaluated.Results: Thirty‐five studies were included in the meta‐analysis. The total number of SG‐FNAs was 10,706, and 7168 of those had histopathologic follow‐up. The ROM for each category was: nondiagnostic, 11.4%; nonneoplastic, 10.9%; atypia of undetermined significance, 30.5%; neoplasm–benign, 2.8%; neoplasm–salivary gland neoplasm of uncertain malignant potential, 37.7%; suspicious for malignancy, 83.8%; and malignant, 97.7%. Low‐level heterogeneity was observed in ROM estimation. The sensitivity, specificity, and diagnostic odds ratio for differentiating malignant and benign lesions were 88.0%, 98.5% and 520.3, respectively.Conclusions: The reporting of SG‐FNA using the MSRSGC demonstrated high diagnostic accuracy. The ROM for each category was generally concordant with the recommendations, except for the suspicious for malignancy category, which was significantly higher than the reference value. The tiered, standardized classification system would benefit the clinical management of salivary gland lesions.


  • Open Access

    A systematic and meta-analysis of heterosexual behaviors and HIV prevalence among Chinese men who have sex with men

    by Huan Zhao, Xi Li, Junhua Wang, Wen Wang, Chunyan Yang, Jingjuan Li, Xiuling Li, Rui Pu, Lulu Chen, Xiao Zhang, et al.

    Men who have sex with men (MSM) are potentially at high risk for HIV infection, their HIV prevalence far exceeds the national prevalence rate. There are also a number of MSM who have sex with women, mostly unprotected, which can transmit HIV to their female sexual partners and even to the next generation. The purpose of this article is to evaluate the prevalence of heterosexual behaviors in Chinese men who have sex with men and the status of condom utilization as well as HIV infection among MSM with heterosexual behaviors, so as to further improve the investigation and prevention and control of AIDS in MSM population. We systematically searched China National Knowledge Infrastructure, Wanfang Data, VIP Database for Chinese Technical Calligraphy (VIP), Pubmed, and Embase following certain retrieval strategies to find relevant articles published from January 1, 2015 to November 18, 2019, The useful information extracted from qualified articles, Stata 15.1 and Review Manager 5.3 were employed for further meta analysis. The estimated prevalence of heterosexual behaviors among MSM in the past year was 19.0% (95% CI 17.0%, 22.0%). The estimated condom utilization rate of the last heterosexual behavior among MSM and condom adherence rate of heterosexual behaviors among MSM were 51.0% (95% CI 44.0%, 58.0%) and 31.0% (95% CI 25.0%, 38.0%), respectively. And the pooled HIV prevalence in MSM with heterosexual behaviors was 9% (95% CI 6%, 13%). The sensitivity analysis showed that the results were stable. No publication bias was found by Egger’s test. There is a high proportion of MSM with heterosexual behaviors and low condom utilization in China. HIV prevalence in MSM with heterosexual behaviors is also high. Therefore, adequate attention should be given to this particular group and measures should be taken in order to reduce the risk of transmission of HIV from subpopulations to the general population.


  • Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China

    by Huan Zhao, HuiQin Guo, LinLin Zhao, Jian Cao, Yue Sun, Cong Wang, ZhiHui Zhang

    Background: The atypia of an undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is a heterogeneous category, which includes various cell patterns. The subclassification of AUS/FLUS was suggested in the 2017 TBSRTC. However, the risk of malignancy (ROM) associated with different subgroups remains unresolved. Herein, AUS/FLUS aspirates were subclassified, from which the ROM of each subgroup was determined.Methods: All cases undergoing fine‐needle aspiration (FNA) from July 2013 to December 2018 were reviewed. Of 12,913 thyroid FNAs, 1053 (8.2%) were AUS/FLUS. The slides of 222 patients with AUS/FLUS with surgical follow‐up were reviewed and subclassified according to the recommendations of the 2017 TBSRTC. There were 195 aspirates consistently diagnosed as AUS/FLUS and subclassified as cytologic atypia 1 (AUS‐C1); cytologic atypia 2 (AUS‐C2); architectural atypia (AUS‐A); cytologic and architectural atypia (AUS‐C&A); Hürthle cell aspirates (AUS‐H); atypia, not otherwise specified (AUS‐NOS); and atypical lymphoid cells, rule out lymphoma (AUS‐L).Results: Malignancy was identified in 83.3% (185 of 222) of the AUS/FLUS nodules. The AUS‐C1 group was the most common (62.1%), followed by the AUS‐C&A (12.8%), AUS‐C2 (10.8%), AUS‐H (6.7%), AUS‐NOS (5.6%), AUS‐L (1.5%), and AUS‐A (0.5%) groups. AUS‐C1 had the highest ROM (92.6%) among the groups and varied significantly from that of the AUS‐C&A (P = .171), AUS‐C2 (P = .001), AUS‐H (P = .001), and AUS‐NOS (P < .001) groups.Conclusions: As a heterogeneous category of TBSRTC, the ROM for AUS/FLUS varies greatly among medical centers. Subclassification of AUS/FLUS might be helpful in identifying nodules with a high ROM in this category and improving the management of such nodules.